Skip to main content
. 2021 Jul 31;13(15):2557. doi: 10.3390/polym13152557

Figure 2.

Figure 2

Influence of the δCL fraction on the yield of drug-loaded PCL NPs (A), influence of the polymer crystallinity on the residual PVA content of drug-loaded PCL NPs (B), apparent degradation represented by the normalized relative count rate (%) after 20 h plotted against the δCL fraction of the copolymers (C) and influence of polymer crystallinity on the efficiency of drug-loaded PCL NPs to inhibit 5-LO product formation (D). Black-circled data points represent PCL polymers with a degree of crystallinity below 10% and a Tg < 37 °C.